Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:e289-e291
Published online before print April 9, 2009, doi: 10.1161/STROKEAHA.108.544569
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/5/e289    most recent
STROKEAHA.108.544569v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dichgans, M.
Right arrow Articles by Hegele, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dichgans, M.
Right arrow Articles by Hegele, R. A.
Related Collections
Right arrow Other Stroke Treatment - Medical

(Stroke. 2009;40:e289.)
© 2009 American Heart Association, Inc.


Advances in Stroke 2008

Update on the Genetics of Stroke and Cerebrovascular Disease 2008

Martin Dichgans, MD Robert A. Hegele, MD, FRCPC, FACP

From the Neurologische Klinik (M.D.), Klinikum Großhadern, Ludwig-Maximilians-Universität, München, Germany; and the Robarts Research Institute and Schulich School of Medicine and Dentistry (R.A.H.), University of Western Ontario, London, Canada.

Correspondence to Martin Dichgans MD, Neurologische Klinik, Klinikum Großhadern, Ludwig-Maximilians-Universität, München, Germany. E-mail martin.dichgans@med.uni-muenchen.de


Key Words: stroke • genetics • genomewide association studies


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
2008 has brought us the first fruits from genomewide association studies (GWASs), an unbiased and comprehensive approach to identify common risk alleles for complex diseases of adulthood. By genotyping >310 000 single nucleotide polymorphisms (SNPs) in over 1700 intracranial aneurysm (IA) cases and 7400 controls from Finland and the Netherlands, a multinational team of investigators recently identified several common SNPs that showed significant association with IA.1 SNPs on chromosomes 2q, 8q and 9p were found to replicate in an independent sample from Japan with similar odds ratios (OR) in all 3 samples. Pooled OR were between 1.24 and 1.36, and analyses of the combined effects suggested a significant linear relationship with risk score in each cohort, with a more than 3-fold increase from the lowest to highest strata. Collectively, the 3 loci were calculated to account for 38% to 46% of the population–attributable fraction of IA, which is substantial. Although additional work in other ethnic groups is required, the consistency emphasizes the robustness of the findings.

The critical genetic intervals on chromosomes 8q and 9p both harbor genes that are implicated in the regulation of stem (progenitor) cell populations and expressed in the adult vasculature. SOX17, the main candidate gene on 8q, is required for both endothelial formation and maintenance—an interesting aspect when considering the predominant location of IA at arterial branch points and sites of endothelial shear stress.

The association between common variants at 9p and IA had already been reported in another study earlier last year.2 The . . . [Full Text of this Article]